GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » OptimizeRx Corp (NAS:OPRX) » Definitions » Cyclically Adjusted PB Ratio

OptimizeRx (OptimizeRx) Cyclically Adjusted PB Ratio : 3.06 (As of May. 14, 2024)


View and export this data going back to 2009. Start your Free Trial

What is OptimizeRx Cyclically Adjusted PB Ratio?

As of today (2024-05-14), OptimizeRx's current share price is $10.695. OptimizeRx's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 was $3.49. OptimizeRx's Cyclically Adjusted PB Ratio for today is 3.06.

The historical rank and industry rank for OptimizeRx's Cyclically Adjusted PB Ratio or its related term are showing as below:

OPRX' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 2.18   Med: 14.16   Max: 56.88
Current: 3.02

During the past years, OptimizeRx's highest Cyclically Adjusted PB Ratio was 56.88. The lowest was 2.18. And the median was 14.16.

OPRX's Cyclically Adjusted PB Ratio is ranked worse than
64.19% of 310 companies
in the Healthcare Providers & Services industry
Industry Median: 1.995 vs OPRX: 3.02

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

OptimizeRx's adjusted book value per share data for the three months ended in Dec. 2023 was $6.969. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $3.49 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


OptimizeRx Cyclically Adjusted PB Ratio Historical Data

The historical data trend for OptimizeRx's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OptimizeRx Cyclically Adjusted PB Ratio Chart

OptimizeRx Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.09 27.54 32.64 6.13 4.10

OptimizeRx Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.13 4.95 4.53 2.33 4.10

Competitive Comparison of OptimizeRx's Cyclically Adjusted PB Ratio

For the Health Information Services subindustry, OptimizeRx's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OptimizeRx's Cyclically Adjusted PB Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, OptimizeRx's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where OptimizeRx's Cyclically Adjusted PB Ratio falls into.



OptimizeRx Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

OptimizeRx's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=10.695/3.49
=3.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OptimizeRx's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, OptimizeRx's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book=Book Value per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=6.969/129.4194*129.4194
=6.969

Current CPI (Dec. 2023) = 129.4194.

OptimizeRx Quarterly Data

Book Value per Share CPI Adj_Book
201403 0.605 99.695 0.785
201406 0.614 100.560 0.790
201409 0.623 100.428 0.803
201412 0.605 99.070 0.790
201503 0.599 99.621 0.778
201506 0.615 100.684 0.791
201509 0.955 100.392 1.231
201512 0.924 99.792 1.198
201603 0.883 100.470 1.137
201606 0.836 101.688 1.064
201609 0.813 101.861 1.033
201612 0.789 101.863 1.002
201703 0.712 102.862 0.896
201706 0.663 103.349 0.830
201709 0.620 104.136 0.771
201712 0.637 104.011 0.793
201803 0.692 105.290 0.851
201806 1.367 106.317 1.664
201809 1.437 106.507 1.746
201812 1.533 105.998 1.872
201903 1.583 107.251 1.910
201906 2.969 108.070 3.556
201909 2.902 108.329 3.467
201912 3.073 108.420 3.668
202003 2.978 108.902 3.539
202006 2.949 108.767 3.509
202009 3.097 109.815 3.650
202012 3.283 109.897 3.866
202103 7.059 111.754 8.175
202106 7.126 114.631 8.045
202109 7.154 115.734 8.000
202112 7.356 117.630 8.093
202203 7.320 121.301 7.810
202206 7.748 125.017 8.021
202209 7.381 125.227 7.628
202212 7.386 125.222 7.634
202303 7.242 127.348 7.360
202306 6.962 128.729 6.999
202309 6.975 129.860 6.951
202312 6.969 129.419 6.969

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


OptimizeRx  (NAS:OPRX) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


OptimizeRx Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of OptimizeRx's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


OptimizeRx (OptimizeRx) Business Description

Traded in Other Exchanges
N/A
Address
400 Water Street, Suite 200, Rochester, MI, USA, 48307
OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its products offering are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.
Executives
Marion Odence-ford officer: General Counsel and CCO 400 WATER STREET, SUITE 200, ROCHESTER MI 48307
Theresa Greco officer: Chief Commercial Officer 260 CHARLES STREET, SUITE 302, WALTHAM MA 02153
Doug Besch officer: Chief Product Officer 400 WATER STREET, SUITE 200, ROCHESTER MI 48307
William J Febbo officer: Chief Executive Officer 600 CALIFORNIA ST., 9TH FLOOR, SAN FRANCISCO CA 94108
James Paul Lang director C/O BIOVIE, 2120 COLORADO AVENUE, SUITE 230, SANTA MONICA CA 90404
Stephen L Silvestro officer: Chief Commercial Officer 400 WATER STREET, SUITE 200, ROCHESTER MI 48307
Ellen O'connor Vos director C/O NTELOS HOLDINGS CORP., 1154 SHENANDOAH VILLAGE DRIVE, WAYNESBORO VA 22980
Edward Stelmakh officer: COO and CFO 400 WATER STREET, SUITE 200, ROCHESTER MI 48307
Miriam J Paramore officer: President 400 WATER STREET, SUITE 200, ROCHESTER MI 48307
Patrick D Spangler director, officer: SVP of Product & Strategy 14405 21ST AVENUE NORTH, MINNEAPOLIS MN 55447
Douglas P Baker officer: Chief Financial Officer 400 WATER STREET, SUITE 200, ROCHESTER MI 48307
Todd Inman officer: Chief Technology Officer 400 WATER STREET, SUITE 200, ROCHESTER MI 48307
Gregory D Wasson director 200 WILMOT ROAD, DEERFIELD IL 60015
Gus D Halas director 38 PHEASANT RUN PLACE, DANVILLE CA 94506
Awm Investment Company, Inc. 10 percent owner 527 MADISON AVENUE, SUITE 2600, NEW YORK NY 10022